AU2002305720A1 - Piperazine pentanamide hiv protease inhibitors - Google Patents
Piperazine pentanamide hiv protease inhibitorsInfo
- Publication number
- AU2002305720A1 AU2002305720A1 AU2002305720A AU2002305720A AU2002305720A1 AU 2002305720 A1 AU2002305720 A1 AU 2002305720A1 AU 2002305720 A AU2002305720 A AU 2002305720A AU 2002305720 A AU2002305720 A AU 2002305720A AU 2002305720 A1 AU2002305720 A1 AU 2002305720A1
- Authority
- AU
- Australia
- Prior art keywords
- pentanamide
- piperazine
- protease inhibitors
- hiv protease
- hiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29437001P | 2001-05-30 | 2001-05-30 | |
US60/294,370 | 2001-05-30 | ||
PCT/US2002/016739 WO2002096359A2 (en) | 2001-05-30 | 2002-05-24 | Piperazine pentanamide hiv protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002305720A1 true AU2002305720A1 (en) | 2002-12-09 |
Family
ID=23133114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002305720A Abandoned AU2002305720A1 (en) | 2001-05-30 | 2002-05-24 | Piperazine pentanamide hiv protease inhibitors |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002305720A1 (en) |
WO (1) | WO2002096359A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6649761B2 (en) * | 2001-05-30 | 2003-11-18 | Merck & Co., Inc. | Process for preparing piperazinepentaneamide HIV protease inhibitors |
EP1658273B1 (en) | 2003-08-20 | 2007-01-03 | Eli Lilly And Company | Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
EP1658285B1 (en) | 2003-08-20 | 2007-05-02 | Eli Lilly And Company | Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE377011T1 (en) * | 1999-11-24 | 2007-11-15 | Merck & Co Inc | GAMMA-HYDROXY-2-(FLUORALKYLAMINOCARBONYL)-1-PIPERAZINE PENTANAMIDE AS AN HIV PROTEASE INHIBITOR |
-
2002
- 2002-05-24 AU AU2002305720A patent/AU2002305720A1/en not_active Abandoned
- 2002-05-24 WO PCT/US2002/016739 patent/WO2002096359A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002096359A2 (en) | 2002-12-05 |
WO2002096359A3 (en) | 2003-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0125445D0 (en) | Protease Inhibitors | |
AU2002305926A1 (en) | Cysteine protease inhibitors | |
AU2003248872A1 (en) | Hiv integrase inhibitors | |
AU2003213776A1 (en) | Carbamates as hiv protease inhibitors | |
AU6007200A (en) | Cysteine protease inhibitors | |
AU2001247589A1 (en) | Non-amidine containing protease inhibitors | |
AU2003257284A1 (en) | Aromatic derivatives as hiv aspartyl protease inhibitors | |
HK1062912A1 (en) | Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors | |
AU2003269984A1 (en) | Protease inhibitors | |
AU1588901A (en) | Protease inhibitors | |
AU1474801A (en) | Protease inhibitors | |
AU2002360673A1 (en) | Gp41 inhibitor | |
AU2002342682A1 (en) | Protease inhibitors | |
AU1474701A (en) | Protease inhibitors | |
AU4066900A (en) | Protease inhibitors | |
AU1474601A (en) | Protease inhibitors | |
AU3888200A (en) | Protease inhibitors | |
AU2002305720A1 (en) | Piperazine pentanamide hiv protease inhibitors | |
AU2003263738A1 (en) | Protease inhibitors | |
GB0123467D0 (en) | Carbocyclic HIV Protease inhibitors | |
AU2001280634A1 (en) | Salt forms of an hiv protease inhibitor | |
AU2003287325A1 (en) | N-cycloalkylglycines as hiv protease inhibitors | |
AU2002255613A1 (en) | Piperazine derivatives as metalloprotease inhibitors | |
AU2002363791A1 (en) | Protease enzyme inhibitors | |
GB0028483D0 (en) | Hydroxyethylamine HIV protease inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |